Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Inst Biochimique Drug Patent Portfolio

Inst Biochimique owns 1 orange book drug protected by 1 US patent Given below is the list of Inst Biochimique's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7723390 Pharmaceutical formulations for thyroid hormones 14 Mar, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Inst Biochimique.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 21 Oct, 2021 US7723390
Payment of Maintenance Fee, 12th Year, Large Entity 23 Sep, 2021 US7691411
Mail Certificate of Correction Memo 23 Feb, 2021 US7723390
Certificate of Correction Memo 18 Feb, 2021 US7723390
Post Issue Communication - Certificate of Correction 18 Feb, 2021 US7723390
Payment of Maintenance Fee, 8th Year, Large Entity 20 Oct, 2017 US7723390
Payment of Maintenance Fee, 8th Year, Large Entity 25 Sep, 2017 US7691411
Patent Issue Date Used in PTA Calculation
Critical
25 May, 2010 US7723390
Recordation of Patent Grant Mailed
Critical
25 May, 2010 US7723390
Issue Notification Mailed
Critical
05 May, 2010 US7723390
Dispatch to FDC 21 Apr, 2010 US7723390
Application Is Considered Ready for Issue
Critical
20 Apr, 2010 US7723390
Issue Fee Payment Received
Critical
09 Apr, 2010 US7723390
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 09 Apr, 2010 US7723390
Issue Fee Payment Verified
Critical
09 Apr, 2010 US7723390


Inst Biochimique's Family Patents

Inst Biochimique drugs have patent protection in a total of 9 countries. It's US patent count contributes only to 11.1% of its total global patent coverage. 8 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Inst Biochimique Drug List

Given below is the complete list of Inst Biochimique's drugs and the patents protecting them.


1. Tirosint

Tirosint is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7723390 Pharmaceutical formulations for thyroid hormones 14 Mar, 2024
(1 year, 7 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tirosint's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List